Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study

Kantonsspital Winterthur KSW

Status: Unknown

Conditions: Peritoneal Carcinomatosis

Study type: Observational

Funder types: Other

Identifiers

NCT03124394

Carcinomatosis studyWinterthur

Details and patient eligibility

About

Evaluation of clinical outcome and economical aspects in the treatment of patients with peritoneal carcinomatosis.

Full description

Peritoneal carcinomatosis is a dooming finding with no hope for cure and a steadily decrease in quality of life. Cytoreductive surgery with intraperitoneal chemotherapy (CRS HIPEC) offers a small but proven chance for cure. The implementation of a CRS HIPEC and PIPAC programme in a Swiss tertiary care hospital is evaluated.

When a patient is deemed non resectable, pressurized intraperitoneal aerosol chemotherapy (PIPAC) administered laparoscopically may confer effective palliation.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and Women >18 years
• Tumour board decision for CRS and intraoperative chemotherapy

Exclusion criteria

• Missing Tumour board decision for CRS and intraoperative chemotherapy
• Pregnancy
• Age <18 years

Trial design

100 participants in 1 patient group

CRS and intraoperative chemotherapy

Description:

Patients receiving cytoreductive surgery and intraoperative chemotherapy (HIPEC/PIPAC)